Nelson Nicholas R, Tompkins Madeline G, Thompson Bastin Melissa L
University of Kentucky HealthCare, Department of Pharmacy Services, United States.
University of Kentucky College of Pharmacy, Department of Pharmacy Practice and Science, United States.
Transfus Apher Sci. 2019 Dec;58(6):102663. doi: 10.1016/j.transci.2019.10.005. Epub 2019 Nov 5.
Osmotic demyelination syndrome (ODS) is characterized by widespread degeneration of myelin within the central nervous system and has no established treatment. A limited number of cases have reported positive outcomes with plasma exchange in the treatment of ODS associated with chronic alcohol abuse or liver transplantation. We report the case of a 23-year-old female presenting with ODS following rapid correction of hyponatremia, which was attributed to hypoalbuminemia, volume overload, and malnutrition secondary to ulcerative colitis. Our patient received four plasma exchange sessions over the course of five days for a total plasma exchange of 15,500 mL. Unfortunately, the patient did not achieve significant neurologic recovery following completion of the plasma exchange regimen. This is the first report of the failure of this novel approach in the management of a patient with ODS, suggesting benefit in a limited patient population. We describe the proposed mechanism of plasma exchange in the treatment of ODS and provide a review of existing literature.
渗透性脱髓鞘综合征(ODS)的特征是中枢神经系统内广泛的髓鞘变性,且尚无既定的治疗方法。少数病例报告称,血浆置换治疗与慢性酒精滥用或肝移植相关的ODS取得了积极效果。我们报告了一例23岁女性病例,该患者在低钠血症快速纠正后出现ODS,病因是溃疡性结肠炎继发的低白蛋白血症、容量超负荷和营养不良。我们的患者在五天内接受了四次血浆置换,血浆置换总量为15500毫升。不幸的是,在完成血浆置换方案后,患者并未实现显著的神经功能恢复。这是首次报道这种新方法在治疗ODS患者时失败,提示仅在有限的患者群体中有益。我们描述了血浆置换治疗ODS的推测机制,并对现有文献进行了综述。